BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Finiuk N, Kryshchyshyn-dylevych A, Holota S, Klyuchivska O, Kozytskiy A, Karpenko O, Manko N, Ivasechko I, Stoika R, Lesyk R. Novel hybrid pyrrolidinedione-thiazolidinones as potential anticancer agents: Synthesis and biological evaluation. European Journal of Medicinal Chemistry 2022;238:114422. [DOI: 10.1016/j.ejmech.2022.114422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Bhat AA, Singh I, Tandon N, Tandon R. Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review). Eur J Med Chem 2023;246:114954. [PMID: 36481599 DOI: 10.1016/j.ejmech.2022.114954] [Reference Citation Analysis]
2 Timaniya JB, Parikh PH, Patel MJ, Dave G, Patel KP. Design, synthesis and evaluation of novel substituted fused pyrido diazepine and pyrimido piperazine derivatives: In vitro cytotoxicity study over various cancer cell lines. Results in Chemistry 2023;5:100707. [DOI: 10.1016/j.rechem.2022.100707] [Reference Citation Analysis]
3 Byun Y, Moon K, Park J, Ghosh P, Mishra NK, Kim IS. Methylene Thiazolidinediones as Alkylation Reagents in Catalytic C–H Functionalization: Rapid Access to Glitazones. Org Lett 2022. [DOI: 10.1021/acs.orglett.2c03677] [Reference Citation Analysis]
4 Lozynskyi A, Senkiv J, Ivasechko I, Finiuk N, Klyuchivska O, Kashchak N, Lesyk D, Karkhut A, Polovkovych S, Levytska O, Karpenko O, Boshkayeva A, Sayakova G, Gzella A, Stoika R, Lesyk R. 1,4-Naphthoquinone Motif in the Synthesis of New Thiopyrano[2,3-d]thiazoles as Potential Biologically Active Compounds. Molecules 2022;27:7575. [DOI: 10.3390/molecules27217575] [Reference Citation Analysis]
5 Roszczenko P, Holota S, Szewczyk OK, Dudchak R, Bielawski K, Bielawska A, Lesyk R. 4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design. IJMS 2022;23:13135. [DOI: 10.3390/ijms232113135] [Reference Citation Analysis]
6 Ivasechko I, Yushyn I, Roszczenko P, Senkiv J, Finiuk N, Lesyk D, Holota S, Czarnomysy R, Klyuchivska O, Khyluk D, Kashchak N, Gzella A, Bielawski K, Bielawska A, Stoika R, Lesyk R. Development of Novel Pyridine-Thiazole Hybrid Molecules as Potential Anticancer Agents. Molecules 2022;27:6219. [DOI: 10.3390/molecules27196219] [Reference Citation Analysis]
7 Rehulka J, Subtelna I, Kryshchyshyn‐dylevych A, Cherniienko A, Ivanova A, Matveieva M, Polishchuk P, Gurska S, Hajduch M, Zagrijtschuk O, Dzubak P, Lesyk R. Anticancer 5‐arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5 H )‐ones as tubulin inhibitors. Archiv der Pharmazie. [DOI: 10.1002/ardp.202200419] [Reference Citation Analysis]